Connection

Hermes Florez to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications Hermes Florez has written about Recombinant Fusion Proteins.
Hermes Florez
Connection Strength
0.295
Recombinant Fusion Proteins
  1. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 2019 07 13; 394(10193):131-138.
    View in: PubMed
    Score: 0.148
  2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 07 13; 394(10193):121-130.
    View in: PubMed
    Score: 0.148
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.